The US OTC drugs market thrives, driven by increasing self-medication trends, diverse product offerings, and growing health ...
A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...